معرفی
Graham Wheeler is an Honorary Senior Lecturer at Imperial College London's School of Public Health (part of the Faculty of Medicine), where he teaches on the MPH course. He holds degrees from the University of Warwick, London School of Hygiene & Tropical Medicine, and Peterhouse, Cambridge, with a PhD focused on adaptive designs in oncology clinical trials. His career includes roles as Deputy Head of Statistics (2021–present) and Acting Head of Statistics (2022) at Imperial’s Clinical Trials Unit, followed by a 2022 appointment as Statistics Director at GSK’s Specialty and Primary Care division.
Education: PhD in Biostatistics (Warwick/London School of Hygiene), MSc/ BSc from Cambridge and Warwick. Professional experience includes post-doctoral work at the MRC Biostatistics Unit, a Senior Statistician role at UCL’s Cancer Trials Centre, and visiting research at Columbia University (funded by MRC).
Research focuses on clinical trial design (adaptive methods, phase I/II trials), oncology, and public health interventions. Key areas include combination therapies, dose-finding algorithms, and statistical innovations in drug development. He has contributed to tools like MoDEsT (dose-escalation analysis) and the PANDA adaptive designs toolkit.
Publications emphasize methodological advancements in clinical trials, including Bayesian adaptive designs, harm reporting in RCTs, and cost-effectiveness analyses of behavioral programs. His work spans oncology, hematology, and infectious disease, with a strong emphasis on translating statistical innovations into practical clinical applications.
Current roles involve leading statistical strategy at GSK while maintaining academic ties at Imperial. No formal student advisees are listed, though his trial leadership roles likely involve collaborative mentoring. Grants and funding details are not explicitly stated in the text.
